Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GW843682X (GW843682) is a selective and ATP-competitive inhibitor of PLK1 and PLK3 (IC50s = 2.2 nM and 9.1 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
無料サンプル 1 mg | |||||
1 mg | 在庫あり | ¥ 7,500 | |||
2 mg | 在庫あり | ¥ 10,500 | |||
5 mg | 在庫あり | ¥ 17,000 | |||
10 mg | 在庫あり | ¥ 30,000 | |||
25 mg | 在庫あり | ¥ 59,500 | |||
50 mg | 在庫あり | ¥ 91,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 18,500 |
説明 | GW843682X (GW843682) is a selective and ATP-competitive inhibitor of PLK1 and PLK3 (IC50s = 2.2 nM and 9.1 nM). |
ターゲット&IC50 | Aurora A:4800 nM, PLK3:9.1 nM, cdk2/cyclin A:7600 nM, PDGFR1β:160 nM, PLK1:2.2 nM, VEGFR2:360 nM |
別名 | GW843682 |
分子量 | 477.46 |
分子式 | C22H18F3N3O4S |
CAS No. | 660868-91-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (62.83 mM), sonification is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GW843682X 660868-91-7 Angiogenesis Cell Cycle/Checkpoint Chromatin/Epigenetic Tyrosine Kinase/Adaptors VEGFR PLK Aurora Kinase CDK PDGFR inhibit GW-843682 GW 843682 Polo-like Kinase (PLK) GW843682 Inhibitor inhibitor